Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer (RTOG 0920) (CIRB)
Conditions
Head and Neck Cancer
Trial Phase
Trial Purpose and Description
Trial Purpose
Participation Guidelines
- Age:
- 18 Years and older
- Gender:
- Both
Eligibility Criteria
- Sponsor:
- Radiation Therapy Oncology Group
- Dates:
- July 2011
- Last Updated:
- Study HIC#:
- 1106008671
Clinicaltrials.gov ID: Yale4333721
